ZEN Graphene Solutions and Trebor RX Announce Successful Inhalation Safety Testing of ZENGuard(TM)-Enhanced Surgical Masks and Final Submission to Health Canada
ZEN Graphene Solutions Ltd. (TSXV:ZEN, OTC PINK:ZENYF) announced successful inhalation safety testing results for its ZENGuardTM-enhanced surgical masks. Conducted by NanoSafe Inc., tests confirmed no graphene release during simulated inhalation rates. This data has been submitted to Health Canada, which is reviewing the application as a priority, with a decision expected soon. CEO Greg Fenton expressed optimism about the commercial viability of ZENGuardTM, aiming to differentiate the product in the PPE market and enhance protection for users.
- Successful inhalation safety testing for ZENGuard-enhanced masks confirmed no graphene release.
- Testing results have been submitted to Health Canada and are being prioritized for review.
- CEO expects commercial viability of ZENGuard, which could enhance market differentiation.
- None.
GUELPH, ON / ACCESSWIRE / June 4, 2021 / ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company and Trebor Rx Corp. (Trebor) are pleased to announce successful inhalation safety testing results of ZENGuardTM-enhanced surgical masks and submission of these results to Health Canada. Testing was completed by NanoSafe Inc. (NanoSafe) in Blacksburg, Virginia confirmed that no ZENGuardTM graphene material was released from the surgical masks with air flow rates simulating resting and light activity inhalation rates. The test results submitted to Health Canada are the final item from the information request ZEN received following the April 2 advisory. Health Canada is reviewing the application as a priority item with a decision expected shortly.
Greg Fenton, ZEN CEO commented: "With the final piece of safety information submitted to Health Canada, we believe our ZENGuardTM-enhanced PPE is poised to become a commercial reality and bring an added level of protection to those that need it most. We remain fully aligned with Health Canada on the need to protect Canadians and value the opportunity to proactively differentiate our product from others in the market. ZEN is focused on developing and commercializing nanotechnologies that help protect people - and we expect our highly-effective, Made-in-Canada solution to do just that."
Inhalation Testing Details
Testing was completed by NanoSafe - a company based in the Virginia Tech Corporate Research Center focused on taking a discipled and rational scientific approach to understanding environmental, health and safety risks related to nanotechnology.
Testing was designed to evaluate particulate release to provide a maximum potential exposure of graphene-containing particles to mask wearers or bystanders in a typical use scenario
Seven coated and uncoated masks were tested with three iterations each measuring the average particulate concentration over one minute
Particulates released during testing were analyzed by scanning electron microscopy with energy-dispersive x-ray spectrometry
On average, airborne particulate concentrations measured during testing of ZENGuardTM coated masks were observed to be lower than those of uncoated masks
At a higher simulated inhalation rate, ZENGuardTM coated masks reduced the particulate concentration in comparison to the cleanroom background, providing further filtration of the cleanroom air
No ZENGuardTM coating was detected in the limited amount of released particulate
For further information:
Greg Fenton, Chief Executive Officer
Tel: 1(437) 220-8140
Email: gfenton@zengraphene.com
About ZEN Graphene Solutions Ltd.
ZEN is a next-gen nanomaterials technology company developing graphene-based technologies that help protect people and the environment. ZEN is currently focused on commercializing ZENGuardTM, a patent pending graphene-based coating with
About Trebor Rx Corp.
Trebor Rx Corp. is led by George Irwin and Brenda Elliott, the 3rd generation Canadian business icons behind the Irwin Toy brand, which has been operating in Canada for almost 100 years. Fueled by a dedicated and compassionate team prioritizing safety and innovation, Trebor is disrupting the PPE industry and setting a new standard of production for masks and face shields while solving problems of cost, comfort, and medical waste. A proudly Canadian company with a production facility located in Collingwood, Ontario, Trebor is committed to providing Healthcare, Frontline, and Essential workers with innovative, new patented technology PPE during COVID-19 and beyond.
To find out more about ZEN Graphene Solutions Ltd., please visit our website at www.ZENGraphene.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN's SEDAR profile at www.sedar.ca.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although ZEN believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. ZEN disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: ZEN Graphene Solutions Ltd.
View source version on accesswire.com:
https://www.accesswire.com/650441/ZEN-GrapheneSolutionsand-Trebor-RX-Announce-Successful-Inhalation-Safety-Testing-of-ZENGuardTM-Enhanced-Surgical-Masks-and-Final-Submission-to-Health-Canada
